CXCL10 and neoplasm: In contrast, in pancreatic, colon or glioblastoma tumors, CXCL10 can activate alternative signaling pathways such as STAT3, which promotes immunosuppression, or PI3K/Akt, which supports tumor cell proliferation and resistance to apoptosis.